AC
CNBS icon

AlphaCore Capital’s Amplify Seymour Cannabis ETF CNBS Stock Holding History

AlphaCore Capital’s Portfolio CNBS Stock Details CNBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204 Hold
7
– – ﹤0.01% 1471
2026
Q1 		$154 Hold
7
– – ﹤0.01% 1197
2025
Q4 		$199 Hold
7
– – ﹤0.01% 1415
2025
Q3 		$207 Hold
7
– – ﹤0.01% 1077
2025
Q2 		$108 Buy
+7
New +$113 ﹤0.01% 1053

Other funds holding CNBS

LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
FLP
Financial Life Planners Tempe, Arizona $156M AUM 23.26% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $21.5B AUM 26.98% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

AlphaCore Capital's CNBS Position: Q2 2026 in Review

AlphaCore Capital held its Amplify Seymour Cannabis ETF (CNBS) position steady in Q2 2026 at 7 shares worth $204. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

AlphaCore Capital first reported a position in CNBS in Q2 2025 and has held it in 5 quarters since. The position peaked at $207 in Q3 2025. 7 funds tracked by Wall St. Rank hold CNBS as of Q2 2026.

  • AlphaCore Capital held 7 shares of Amplify Seymour Cannabis ETF worth $204 as of Q2 2026.
  • AlphaCore Capital left its Amplify Seymour Cannabis ETF share count unchanged in Q2 2026.
  • Amplify Seymour Cannabis ETF made up ﹤0.01% of AlphaCore Capital's portfolio in Q2 2026, its #1471 holding.
  • AlphaCore Capital first reported a position in Amplify Seymour Cannabis ETF in Q2 2025 and has held it in 5 quarters since.
  • AlphaCore Capital's Amplify Seymour Cannabis ETF position peaked at $207 in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Amplify Seymour Cannabis ETF as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.